Understanding the Acceptability of Depot Medroxyprogesterone Acetate (ANTARA) among Women of Reproductive Age from the Lens of Grassroot Level Providers in Rural and Urban Areas of Nagpur, India.

Context: Depot medroxyprogesterone acetate (DMPA), marketed as ANTARA, is a long-acting contraceptive with minimal daily interference. Despite its availability, its uptake remains low in India, with only 0.4% of women using injectables (NFHS-5). This study explores the acceptability of DMPA among women in rural and urban Nagpur.

Objective: The objective of the study was to examine the acceptability of DMPA among women of reproductive age in Nagpur.

Methods: A constructivist paradigm and descriptive design were employed at the Urban Health Centre (PHC), Nandanvan and Rural Health Training Center, Bela Nagpur, India. Data were collected from 21 Accredited Social Health Activists (ASHAs) using free listing, pile sorting, and focus group discussions. Analysis included Smith's salience score, cognitive mapping, and thematic categorization.

Results: Pile sorting identified three major clusters: Menstrual-related concerns, general perceptions, and service delivery barriers. ASHA interviews revealed five key barriers: menstrual and physical side effects, social and cultural factors, health concerns, misunderstandings, and preference for alternative methods.

Conclusion: Findings indicate the need for pre-administration counseling, enhanced ASHA training for community education, and sharing positive user experiences to improve DMPA uptake.